Anti-cancer efficiency of natural killer cells differentiated from human adipose tissue-derived mesenchymal stem cells and transfected with miRNA150
dc.contributor.author | Karlitepe A. | |
dc.contributor.author | Kabadayi H. | |
dc.contributor.author | Vatansever S. | |
dc.contributor.author | Gurdal M. | |
dc.contributor.author | Gunduz C. | |
dc.contributor.author | Ercan G. | |
dc.date.accessioned | 2024-07-22T08:10:44Z | |
dc.date.available | 2024-07-22T08:10:44Z | |
dc.date.issued | 2017 | |
dc.description.abstract | Aim: The aim of this study is to investigate the effects of miR150 transfection on NK-like cells differentiated from adipose tissue derived mesenchymal stem cells (AD-MSCs). Methods: NK-like cells were differentiated from AD-MSCs and activated by miR150 transfection. Transfected/non-Transfected NK-like cells were characterized by immunohistochemical and RTPCR analyzes. Apoptotic efficiency of the transfected/non-Transfected NK-like cells on pancreatic cancer cells PANC1 were determined by TUNEL and RT-PCR. Results: In miR150-Transfected cells, the increased expression of NK cell-specific genes such as GKMB, KIR2DL2, CD16, CD56, NKG2D, NKp46 and increased immunoreactivity of NK cell-specific surface marker CD314 (NKG2D) were evident. TUNEL assays showed that NK-like cells with/without transfection induced apoptosis in PANC1 cells in the same manner. The decrease in oncogene expression and the increase in the tumor suppressor gene expression in PANC1 cells upon co-culture with NK-like cells differentiated from AD-MSCs were more prominent following miRNA150 transfection. Conclusion: It was shown in vitro that NK-like cells could be obtained by differentiation from AD-MSCs and their efficiency could be increased via miR150 transfection. The results are encouraging for further clinical studies in improvement of immunotherapeutic approaches for cancer therapy. Copyright © Experimental Oncology, 2017. | |
dc.identifier.DOI-ID | 10.31768/2312-8852.2017.39(3):212-218 | |
dc.identifier.issn | 18129269 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/15370 | |
dc.language.iso | English | |
dc.publisher | Morion LLC | |
dc.rights | All Open Access; Green Open Access | |
dc.subject | Adipose Tissue | |
dc.subject | Apoptosis | |
dc.subject | Biomarkers | |
dc.subject | Cell Differentiation | |
dc.subject | Cell Line, Tumor | |
dc.subject | Cells, Cultured | |
dc.subject | Coculture Techniques | |
dc.subject | Cytotoxicity, Immunologic | |
dc.subject | Gene Expression | |
dc.subject | Humans | |
dc.subject | Killer Cells, Natural | |
dc.subject | Mesenchymal Stromal Cells | |
dc.subject | MicroRNAs | |
dc.subject | Neoplasms | |
dc.subject | Transfection | |
dc.subject | microRNA | |
dc.subject | microRNA 150 | |
dc.subject | natural killer cell receptor NKG2D | |
dc.subject | unclassified drug | |
dc.subject | biological marker | |
dc.subject | microRNA | |
dc.subject | MIRN150 microRNA, human | |
dc.subject | adipose tissue cell | |
dc.subject | adipose tissue derived mesenchymal stem cell | |
dc.subject | antineoplastic activity | |
dc.subject | apoptosis | |
dc.subject | Article | |
dc.subject | CD16 gene | |
dc.subject | CD56 gene | |
dc.subject | cell differentiation | |
dc.subject | coculture | |
dc.subject | controlled study | |
dc.subject | gene expression regulation | |
dc.subject | genetic transfection | |
dc.subject | GKMB gene | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | immunohistochemistry | |
dc.subject | immunoreactivity | |
dc.subject | KIR2DL2 gene | |
dc.subject | mesenchymal stem cell | |
dc.subject | natural killer cell | |
dc.subject | NK cell culture | |
dc.subject | NKG2D gene | |
dc.subject | NKp46 gene | |
dc.subject | oncogene | |
dc.subject | PANC-1 cell line | |
dc.subject | reverse transcription polymerase chain reaction | |
dc.subject | stem cell culture | |
dc.subject | tumor suppressor gene | |
dc.subject | TUNEL assay | |
dc.subject | upregulation | |
dc.subject | adipose tissue | |
dc.subject | cell culture | |
dc.subject | cell differentiation | |
dc.subject | cytology | |
dc.subject | cytotoxicity | |
dc.subject | gene expression | |
dc.subject | genetics | |
dc.subject | immunology | |
dc.subject | mesenchymal stroma cell | |
dc.subject | metabolism | |
dc.subject | natural killer cell | |
dc.subject | neoplasm | |
dc.subject | pathology | |
dc.subject | tumor cell line | |
dc.title | Anti-cancer efficiency of natural killer cells differentiated from human adipose tissue-derived mesenchymal stem cells and transfected with miRNA150 | |
dc.type | Article |